Teknova Announces New Board Member, Martha J. Demski
August 16, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova Reports Second Quarter 2023 Financial Results
August 10, 2023 16:01 ET
|
Alpha Teknova, Inc.
Second quarter 2023 total revenue was $11.5 million, up 26% sequentiallyReceived certification of new state-of-the-art facility for production of GMP-grade productsCompany revises 2023 revenue...
Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
August 09, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023
July 26, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of...
Teknova and Sartorius BIA Separations Share Data Demonstrating Reliable and Scalable Approach for the Enhancement of AAV Full Capsid Enrichment with an Optimized AEX Platform
July 20, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Sartorius BIA Separations, which is part of the international life science group Sartorius,...
Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for Gene Therapy Process Development
July 11, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova to Participate in Upcoming Investor Conference
May 25, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Reports First Quarter 2023 Financial Results
May 10, 2023 16:01 ET
|
Alpha Teknova, Inc.
First quarter 2023 total revenue was $9.1 million, up 16% sequentially Launch of proprietary AAV-Tek™ Solutions gene therapy product line Company reaffirms 2023 revenue guidance of $42-46 million ...
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting
May 10, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Announces Time Change for First Quarter 2023 Financial Results Conference Call on May 10, 2023
May 04, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...